Valensa’s Leadership in Supply Chain Featured in NutraIngredients
In the face of climate unpredictability, Valensa’s GEMS Supply Chain Excellence Program is leading the way in securing supply chain reliability.
Read More »Study explores FlexPro MD’s synergistic effect on joint pain and function
FlexPro MD, a multi-ingredient supplement designed to combat inflammation, is well tolerated and effective in reducing joint pain and improving physical function in patients with mild osteoarthritis, according to a recent study. “This 12-week intervention trial demonstrated that intake of FP-MD, a unique formulation of three synergistic ingredients (e.g., omega-3 fatty acids (EPA/DHA), astaxanthin, and […]
Read More »Study highlights importance of quality and potency of saw palmetto extracts in prostate health supplements
7 out of 28 popular products studied contain the amount of authentic saw palmetto extract shown to be clinically effective in relieving lower urinary tract symptoms affecting millions of men EUSTIS, FLA. – A new study published in the Journal of Urology Open Plus reveals that 7 saw palmetto products met the identity and potency […]
Read More »Valensa CEO Discusses Astaxanthin Market Dynamics in Recent Article
In an interview at the SupplySide West trade show in Las Vegas, Valensa CEO Umasudan (Uma) Pal., noted that while the astaxanthin market has experienced growth over the last decade, “even golden-egg-laying geese can inadvertently be slaughtered.” To learn more about this antioxidant powerhouse, quality and consumer benefits read the entire article.
Read More »Spotting “Sham” Palmetto: Based on the USP Monograph, Valensa Tests Reveal Rampant Adulteration
Scientists analyzed nutritional profiles of products labeled “Saw Palmetto extract,” finding little, if any, of the key fatty acids necessary to support prostate health; FREE report available ORLANDO, Florida (April 28, 2021) – Scientists from Valensa International tested market samples labeled as ‘Saw Palmetto extract’ from different suppliers and found that all the samples were […]
Read More »Valensa’s USPlus® Remains First, Only US Pharmacopeia Verified Saw Palmetto Extract For Third Year In A Row
USPlus® Pure Lipidosterolic Extract of Saw Palmetto, derived from Valensa’s GEMS Supply Chain Excellence Program, delivers an effective product and enables brands to meet emerging Amazon requirements ORLANDO, Fla. (April 5, 2021) — Valensa International announced today that for a third consecutive year the company’s USPlus® Pure Lipidosterolic Extract of Saw Palmetto, is the only […]
Read More »Valensa Raises the Bar in Prostate Health
New video and USPlus® logo reflect company’s commitment to truth and transparency for consumers ORLANDO, Fla. (January 27, 2021) — Since the launch of USPlus® in 2002, the industry has been faced with a dramatic shift in product quality, largely due to the proliferation of crushed saw palmetto berry powder supplements and adulterated products that […]
Read More »Saw Palmetto Efficacy and Evidence: Video Series
Valensa International introduces a new Saw Palmetto video series, featuring Chief Science Officer Margaret H. Dohnalek, PhD. Dr. Dohnalek describes the breadth of research on saw palmetto lipidosterolic extract derived from this special berry, and the scientific evidence for a standardized extract that supports a healthy prostate.
Read More »Valensa To Commercialize Algal Scientific Algae-Based Immune Health Ingredients in U.S. Human Health & Nutrition Markets
Company Has Successfully Completed In-vitro Clinical Trial Work and is Now Advancing into Human Clinical Trials on Immunum™ Line Orlando, FL 17 January 2017 – Valensa International (Eustis, FL USA) announced today that it has reached an agreement with Algal Scientific Corporation (Plymouth, MI USA) to commercialize Algal’s PureAlgalTM branded ingredients – whole dried microalgae (Euglena […]
Read More »